Haohai Biotec Allocates HK$3.94 Million to Buy Back Nearly 250,000 Shares
Stock News
Aug 24
Haohai Biotec (06826) announced that on August 24, it spent approximately HK$3.939 million to repurchase 249,600 of its own shares.
This buyback reflects the company's ongoing capital management strategy, utilizing its financial resources to consolidate shareholder value. The transaction was executed on the open market at prevailing prices.
Following the repurchase, the company's total issued share capital has been correspondingly reduced, which may enhance the earnings per share metric for existing investors.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.